当前位置:首页 - 行情中心 - 云南白药(000538) - 财务分析

云南白药

(000538)

  

流通市值:989.75亿  总市值:996.15亿
流通股本:17.73亿   总股本:17.84亿

云南白药(000538)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润47.89亿元,每股收益2.68元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益3981787.36万元,未分配利润1782594.43万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产5334348.47万元,负债1352561.11万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入30,654,214,209.0121,257,102,896.0210,841,237,721.2940,033,300,814.72
营业总成本26,074,760,939.8617,836,286,155.078,751,171,876.2635,206,797,286.5
其他经营收益
营业利润5,605,052,816.154,220,316,255.722,255,305,450.435,711,621,822.28
利润总额5,615,098,543.694,231,871,841.792,255,981,3955,684,719,663.99
净利润4,789,170,075.423,644,599,967.941,927,511,203.494,767,072,360.28
每股收益
其他综合收益3,052,405.374,613,102.15-122,538.7-13,441,329.34
综合收益总额4,792,222,480.793,649,213,070.091,927,388,664.794,753,631,030.94
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计33,776,781,451.6435,074,714,780.1435,436,604,060.534,150,663,141.08
非流动资产:
非流动资产合计19,566,703,269.7519,460,775,923.9318,816,422,257.1418,763,518,191.97
资产总计53,343,484,721.3954,535,490,704.0754,253,026,317.6452,914,181,333.05
流动负债:
流动负债合计12,366,323,961.7112,813,745,845.5912,240,342,494.1812,858,491,395.24
非流动负债:
非流动负债合计1,159,287,149.071,220,771,222.611,217,714,657.531,189,605,375.54
负债合计13,525,611,110.7814,034,517,068.213,458,057,151.7114,048,096,770.78
所有者权益(或股东权益):
归属于母公司股东权益合计39,733,402,690.0240,406,601,054.1540,768,110,417.8738,831,946,424.51
股东权益合计39,817,873,610.6140,500,973,635.8740,794,969,165.9338,866,084,562.27
负债和股东权益合计53,343,484,721.3954,535,490,704.0754,253,026,317.6452,914,181,333.05
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计34,692,435,604.924,002,572,014.210,830,762,784.1643,880,006,829.37
经营活动现金流出小计30,236,466,093.3620,041,384,811.4310,117,165,224.5139,583,003,687.1
经营活动产生的现金流量净额4,455,969,511.543,961,187,202.77713,597,559.654,297,003,142.27
投资活动产生的现金流量:
投资活动现金流入小计4,868,926,894.342,531,420,210.39946,127,434.078,019,213,440.17
投资活动现金流出小计7,082,314,175.113,486,707,527.531,012,765,741.899,218,214,486.64
投资活动产生的现金流量净额-2,213,387,280.77-955,287,317.14-66,638,307.82-1,199,001,046.47
筹资活动产生的现金流量:
筹资活动现金流入小计156,213,144.52133,715,072.0316,000,439.391,962,072,461.45
筹资活动现金流出小计4,626,307,191.812,717,556,950.46487,209,760.468,939,807,625.33
筹资活动产生的现金流量净额-4,470,094,047.29-2,583,841,878.43-471,209,321.07-6,977,735,163.88
汇率变动对现金及现金等价物的影响-6,359,311.98-5,088,619.221,032,499.263,497,174.93
现金及现金等价物净增加额-2,233,871,128.5416,969,387.98176,782,430.02-3,876,235,893.15
期末现金及现金等价物余额8,041,658,446.8410,692,498,963.3210,452,312,005.3610,275,529,575.34
补充资料:
现金及现金等价物的净增加额-416,969,387.98--3,876,235,893.15
最新报告期:2025-11-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西部证券陆伏崴2.913.183.472025-11-30
东方证券伍云飞,赵博宇2.863.143.442025-11-05
中信建投袁全,刘若飞,贺菊颖2.873.153.482025-11-04
中信证券宋硕,陈竹,李文涛2.943.123.412025-11-03
中金公司张琎,朱言音,杨一正2.933.22--2025-11-01
TOP↑